Says liquidity, capital position "remain excellent." Expects 2H23 earnings to represent slightly more than 50% of FY total. Expects Q3 earnings "slightly higher" than Q4. Sees FY23 CapEx $2.8B-$3B.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CVS: